New quinoline derivatives: Synthesis and investigation of antibacterial and antituberculosis properties

dc.contributor.authorEswaran, S.
dc.contributor.authorVasudeva Adhikari, A.V.
dc.contributor.authorChowdhury, I.H.
dc.contributor.authorPal, N.K.
dc.contributor.authorThomas, K.D.
dc.date.accessioned2026-02-05T09:36:29Z
dc.date.issued2010
dc.description.abstractFour new series of quinoline derivatives were synthesized starting from 2-trifluoromethyl aniline through multi-step reactions. In the reaction sequence,substituted aniline was cyclized to 4-hydroxy quinoline 1,which was then transformed to 4-chloro-2,8-bis(trifluoromethyl)quinoline 2. The key scaffold 4-hydrazinyl-2,8-bis(trifluoromethyl)quinoline 3,obtained from the compound 2,was successfully converted to target quinoline derivatives,viz. hydrazones 4aet,ureas 5aee,thioureas 6aec and pyrazoles 7aed,in good yields. The newly synthesized title compounds were evaluated for their in vitro antibacterial activity against Escherichia coli,Staphylococcus aureus,Pseudomonas aeruginosa and Klebsiella pneumoniae (recultured) and antituberculosis activity against Mycobacterium tuberculosis H<inf>37</inf>Rv and MDR-TB. Preliminary results indicated that most of the hydrazone derivatives demonstrated very good antibacterial and antituberculosis activities while other derivatives showed moderate activity. © 2010 Elsevier Masson SAS. All rights reserved.
dc.identifier.citationEuropean Journal of Medicinal Chemistry, 2010, 45, 8, pp. 3374-3383
dc.identifier.issn2235234
dc.identifier.urihttps://doi.org/10.1016/j.ejmech.2010.04.022
dc.identifier.urihttps://idr.nitk.ac.in/handle/123456789/27537
dc.publisherElsevier Masson SAS
dc.subject1 (2,8 bis(trifluoromethyl)quinolin 4 yl) 2 (2 fluoro 4 methoxybenzylidene)hydrazine
dc.subject1 (2,8 bis(trifluoromethyl)quinolin 4 yl) 2 (3 hydroxy 4 methoxybenzylidene)hydrazine
dc.subject1 (2,8 bis(trifluoromethyl)quinolin 4 yl) 2 (cyclohexylmethylene)hydrazine
dc.subject1 (2,8 bis(trifluoromethyl)quinolin 4 yl) 2 2 [(benzo[c][1,2,5]oxadiazol 5 yl)methylene]hydrazine
dc.subject1 (2,8 bis(trifluoromethyl)quinolin 4 yl) 2 octylidenehydazine
dc.subject1 (2,8 bis(trifluoromethyl)quinolin 4 yl) 2 [(1 methyl 1h benzo[d][1,2,3]triazol 5 yl)methylene]hydrazine
dc.subject1 (2,8 bis(trifluoromethyl)quinolin 4 yl) 2 [(1 methyl 1h pyrrol 2 yl)methylene]hydrazine
dc.subject1 (2,8 bis(trifluoromethyl)quinolin 4 yl) 2 [(2,3 dihydrobenzofuran 5 yl)methylene]hydrazine
dc.subject1 (2,8 bis(trifluoromethyl)quinolin 4 yl) 2 [(4 bromofuran 3 yl)methylene]hydrazine
dc.subject1 (2,8 bis(trifluoromethyl)quinolin 4 yl) 2 [(4 chloro 1 methyl 1h pyrazol 3 yl)methylene]hydrazine
dc.subject1 (2,8 bis(trifluoromethyl)quinolin 4 yl) 2 [(4 methyl 1h imidazol 5 yl)methylene]hydrazine
dc.subject1 (2,8 bis(trifluoromethyl)quinolin 4 yl) 2 [(5 (acetoxymethyl)furan 2 yl)methylene]hydrazine
dc.subject1 (2,8 bis(trifluoromethyl)quinolin 4 yl) 2 [(5 methoxy 1h indol 3 yl)methylene]hydrazine
dc.subject1 (2,8 bis(trifluoromethyl)quinolin 4 yl) 2 [(7 methyl 1h indol 3 yl)methylene]hydrazine
dc.subject1 (2,8 bis(trifluoromethyl)quinolin 4 yl) 2 [(pyridin 3 yl)methylene]hydrazine
dc.subject1 (2,8 bis(trifluoromethyl)quinolin 4 yl) 2 [(thiophen 2 yl)methylene]hydrazine
dc.subject1 (2,8 bis(trifluoromethyl)quinolin 4 yl) 2 [3 (trifluoromethoxy)benzylidene]hydrazine
dc.subject1 (2,8 bis(trifluoromethyl)quinolin 4 yl) 4 (3 cyanophenyl)semicarbazide
dc.subject1 (2,8 bis(trifluoromethyl)quinolin 4 yl) 4 (4 fluorophenyl)semicarbazide
dc.subject1 (2,8 bis(trifluoromethyl)quinolin 4 yl)2 (3 (1,1,2,2 tetrafluoroethoxy)benzylidene)hydrazine
dc.subject2 [(1h imidazol 4 yl)methylene] 1 [2,8 bis(trifluoromethyl)quinolin 4 yl]hydrazine
dc.subject2 [[2 [2,8 bis(trifluoromethyl)quinolin 4 yl]hydrazinylidene]methyl] 5 fluorophenol
dc.subjectantiinfective agent
dc.subjecthydrazone derivative
dc.subjectpyrazole derivative
dc.subjectquinoline derivative
dc.subjectthiourea derivative
dc.subjecttuberculostatic agent
dc.subjectunclassified drug
dc.subjectunindexed drug
dc.subjecturea derivative
dc.subjectantibacterial activity
dc.subjectarticle
dc.subjectdrug synthesis
dc.subjectEscherichia coli
dc.subjectin vitro study
dc.subjectKlebsiella pneumoniae
dc.subjectmultidrug resistant tuberculosis
dc.subjectMycobacterium tuberculosis
dc.subjectnonhuman
dc.subjectPseudomonas aeruginosa
dc.subjectStaphylococcus aureus
dc.titleNew quinoline derivatives: Synthesis and investigation of antibacterial and antituberculosis properties

Files

Collections